Company Performance Metrics
Bryan Berger: Founder and Chief Scientific Officer- Timothy Heydon: Chief Executive OfficerPast Role: Soli Organic, Founder & Chief Executive Officer
Lytos is a biotechnology platform company developing innovative solutions to combat antimicrobial resistance (AMR) and improve microbial control across food, water, and human health. The company’s platform includes technologies that disrupt bacterial biofilms, actively kill harmful pathogens, and replace traditional chemical interventions with
safer, sustainable alternatives, including its proprietary biofungicides and next-generation microbial control products.
By combining biofilm-targeting strategies with pathogen-killing capabilities, Lytos addresses both persistent contamination and acute microbial threats. Its solutions are designed to integrate into existing industrial, food, and health systems, providing safer food production, cleaner water systems, and enhanced protection against resistant pathogens.
Founded on proprietary intellectual property and advanced biotechnology, Lytos is building a scalable platform that goes beyond traditional biocontrol approaches. The company’s multi-pronged technology enables practical, chemistry-free alternatives that reduce reliance on antibiotics, chemical fungicides, and other conventional antimicrobial agents, while maintaining efficacy against a broad spectrum of microbial threats.